ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy.

Peter S Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.